Related Experiment Video
Updated: Aug 22, 2026

Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants
Published on: June 13, 2021
Importance of Preconception Care for Optimizing Fetal Growth in Pregnancies Complicated by Psychiatric Disorders
Hitoshi Isohata1, Sumie Miura2, Yu Yamazaki1
1Department of Obstetrics and Gynecology, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan.
Insights
Maternal background factors, not psychotropic medications, significantly impact fetal growth abnormalities like large for gestational age (LGA) and small for gestational age (SGA) in pregnancies with psychiatric disorders.
Area of Science:
- Perinatology
- Psychiatry
- Reproductive Health
Background:
- Pregnancies with maternal psychiatric disorders present unique challenges for fetal development.
- Fetal growth abnormalities, including large for gestational age (LGA) and small for gestational age (SGA) infants, require investigation into their specific determinants.
- Understanding these determinants is crucial for improving perinatal outcomes.
Purpose of the Study:
- To investigate the factors influencing fetal growth abnormalities (LGA and SGA) in singleton pregnancies affected by maternal psychiatric disorders.
- To specifically examine the impact of psychotropic medication exposure and maternal background factors on infant growth.
Main Methods:
- A retrospective cohort study of 400 singleton pregnancies with maternal psychiatric disorders (2019-2023).
- Data collected included maternal characteristics, psychiatric diagnoses, psychotropic medication use (including polypharmacy and metabolically high-risk medications), and obstetric outcomes.
- Multivariable logistic regression analysis was used to identify independent risk factors for LGA and SGA.
Main Results:
- Psychotropic medication use (including polypharmacy and metabolically high-risk types) was not independently associated with LGA or SGA.
- High prepregnancy BMI was the sole independent risk factor identified for LGA.
- Hypertensive disorders of pregnancy, maternal alcohol consumption, and lower prepregnancy BMI were independently associated with SGA.
Conclusions:
- Fetal growth abnormalities in pregnancies with psychiatric disorders are primarily linked to maternal background factors.
- No significant association was found between psychotropic medication use and LGA or SGA in this cohort.
- Preconception care optimizing metabolic health and lifestyle is recommended to improve fetal growth outcomes.
Aim:
To investigate the determinants of fetal growth abnormalities such as large for gestational age (LGA) and small for gestational age (SGA) in singleton pregnancies complicated by maternal psychiatric disorders, particularly focusing on the impact of psychotropic medication exposure and maternal background factors on infants.
Methods:
A retrospective single-center cohort study was conducted involving 400 singleton pregnancies complicated by maternal psychiatric disorders, with deliveries occurring between 2019 and 2023. Data regarding maternal characteristics, psychiatric diagnoses, psychotropic medication use including polypharmacy and metabolically high-risk psychotropic medications, and obstetric outcomes were extracted from medical records. Infants were classified as LGA or SGA according to gestational age-specific birth weight standards. Multivariable logistic regression analyses were performed to identify independent factors associated with LGA and SGA.
Results:
Of the 400 pregnancies, 40 infants were classified as LGA and 40 as SGA. Psychotropic medication use, including polypharmacy and metabolically high-risk psychotropic medications, was not independently associated with either LGA or SGA. For LGA, only high prepregnancy BMI was identified as an independent risk factor. For SGA, hypertensive disorders of pregnancy, maternal alcohol consumption, and lower prepregnancy BMI were independently associated with increased risk.
Conclusions:
In pregnancies complicated by psychiatric disorders, fetal growth abnormalities were primarily associated with maternal background factors. No statistically significant association was identified between psychotropic medication use and LGA or SGA fetuses in our study cohort. These findings highlight the potential importance of preconception care focused on optimizing metabolic health and lifestyle factors to improve fetal growth outcomes.
More Related Videos
05:44Concurrent Collection of Fetal Murine Brain and Serum to Assess Effects of Maternal Diet on Nutrition and Neurodevelopment in Neurofibromatosis Type 1
Published on: May 17, 2024
03:19Modifying Levels of Maternal Dietary Folic Acid or Choline to Study the Impact of Deficiencies on Offspring Health Outcomes
Published on: June 28, 2024
Related Concept Videos
Teratogenicity
Preventive Healthcare Services
Psychological and Sociocultural Causes of Schizophrenia
Bulimia Nervosa
Psychosurgery
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...